Related Experiment Video
Updated: Aug 16, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C
Lily Shen1, Chuong Bui, Robert Mansberg
1Department of Nuclear Medicine, Nepean Hospital, Penrith, New South Wales, Australia. lshen@bigpond.com
Abstract:
Interferon-alpha therapy is well known to induce a wide range of thyroid dysfunction. A 22-year-old woman with chronic hepatitis C developed overt hyperthyroidism while on interferon-alpha and ribavirin therapy. Tc-99m thyroid scintigraphy demonstrated virtually absent tracer uptake consistent with subacute thyroiditis. Ten months after starting antiviral therapy, overt hyperthyroidism recurred. Repeat thyroid scintigraphy revealed diffusely increased tracer uptake throughout the thyroid gland consistent with Graves disease. This is an unusual case of 2 forms of hyperthyroidism-confirmed scintigraphically and occurring in the same patient over time while on interferon-alpha therapy.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hypothyroidism II: Pathophysiology
Hyperthyroidism II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hyperthyroidism I: Introduction

